IRS Finalizes RMD Regulations: Key Takeaways and the 10-Year Rule for Beneficiaries

The IRS issued its highly anticipated final regulations for required minimum distributions on July 19, 2024. These regulations incorporate rules from both the Secure and Secure 2.0 acts.

Read More

Biden’s Fragile Legacy On Health Care

President Biden — who was propelled into office in no small part by his health care agenda — realized Democrats' decades-long dream of allowing Medicare to negotiate prescription drug prices, and came closer to achieving his party's equally elusive goal of universal health coverage than any other Democratic president before him.

Read More

Medical Stop-Loss Premiums Rise 11.5% For Self-Funded Plans

Expensive specialty drugs and ordinary severe claims are pushing the cost of protecting a self-funded employer health plan against catastrophic risk higher.

Read More

Misleading Ads Play Key Role in Schemes to Gin Up Unauthorized ACA Sign-Ups, Lawsuit Alleges

The government is giving away money! So say ads on a variety of social media platforms. Consumers, the ads claim, can qualify for $1,400 or even $6,400 a month to use on groceries, rent, medical expenses, and other bills. Some mention no-cost health insurance coverage. But that’s not the whole story. And here’s the spoiler — no one ...

Read More

Why Millions Are Trying FDA-Authorized Alternatives to Big Pharma’s Weight Loss Drugs

Pharmacist Mark Mikhael has lost 50 pounds over the past 12 months. He no longer has diabetes and finds himself “at my ideal body weight,” with his cholesterol below 200 for the first time in 20 years. “I feel fantastic,” he said. Like millions of others, Mikhael credits the new class of weight loss drugs. ...

Read More

Drug Middlemen Are Pushing Patients To Pay For More Expensive Drugs, House Investigation Found

Pharmacy-benefit managers (PBMs) are steering patients toward more expensive drugs and limiting where they can get them, according to a new report from the House Committee on Oversight and Accountability. The report, viewed by the Wall Street Journal, followed a 32-month investigation by the committee ahead of a hearing on PBMs involving executives from the nation’s largest ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square